Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.04
3% from low
Exchange
OTC Link
OS
IMPEDIMED LTD ORD
No one on the platform currently holds IPDQF.
No tracked institution reports a position in IPDQF as of their last filing.
No one on the platform has traded IPDQF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $14M | +36.4% | $-0.00 | $-0.00–$-0.00 | — | 1 |
| 2028 | $20M | +40.2% | $-0.00 | $-0.00–$-0.00 | — | 1 |
| 2029 | $22M | +8.9% | $-0.00 | $-0.00–$-0.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-02-25 | $-0.00 | $-0.00 | -200.8% |
| 2025-07-31 | $-0.00 | $-0.00 | -99.0% |
| 2025-02-24 | $-0.00 | $-0.00 | +88.0% |
| 2024-10-21 | $-0.00 | $-0.00 | +18.0% |
| 2024-04-30 | $-0.00 | $-0.00 | +2.6% |
| 2022-12-31 | $-0.00 | $-0.00 | -1.5% |
| 2022-06-30 | $-0.00 | $-0.00 | -2.4% |
| $11M |
| — |
| ELXMFNova Eye Medical Limited | $0.01 | +0.00% | $4M | — |
| FNCHFinch Therapeutics Group, Inc. | $10.20 | +0.99% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry